BioCentury
ARTICLE | Clinical News

FermaVir preclinical data

June 26, 2006 7:00 AM UTC

Data from in vitro studies showed that at the highest dose of FV-100, the active compound exceeded by 50,000 times the EC50 required for antiviral activity against varicella zoster, the causative viru...